Blueprint Medicines Executives Sell Shares for Tax Obligations
Okuma süresi: 1 dakikadan kısa
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Carter Percy H. | CHIEF SCIENTIFIC OFFICER | Sell | $134,790 | Form 4 |
| Rossi Christina | CHIEF OPERATING OFFICER | Sell | $150,309 | Form 4 |
Blueprint Medicines Corp's executives have recently sold shares to cover tax obligations related to the vesting of restricted stock units.
Carter Percy H., the company's Chief Scientific Officer, sold 1,051 shares of common stock on July 3, 2025, at a price of $128.25 per share, totaling $134,790. Following this transaction, Carter Percy H. directly owns 53,155 shares of Blueprint Medicines Corp.
Christina Rossi, the Chief Operating Officer of Blueprint Medicines Corp, sold 1,172 shares of common stock on the same date, at a price of $128.25 per share, totaling $150,309. After this sale, Rossi directly owns 63,546 shares of the company.